Macquarie Group’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,637
| Closed | -$139K | – | 2266 |
|
|
2022
Q3 | $139K | Sell |
2,637
-93
| -3% | -$4.9K | ﹤0.01% | 1678 |
|
|
2022
Q2 | $88K | Hold |
2,730
| – | – | ﹤0.01% | 1898 |
|
|
2022
Q1 | $90 | Hold |
2,730
| – | – | ﹤0.01% | 1978 |
|
|
2021
Q4 | $116K | Sell |
2,730
-633
| -19% | -$26.9K | ﹤0.01% | 1887 |
|
|
2021
Q3 | $149K | Buy |
3,363
+1,685
| +100% | +$74.7K | ﹤0.01% | 1857 |
|
|
2021
Q2 | $95K | Sell |
1,678
-22
| -1% | -$1.25K | ﹤0.01% | 1986 |
|
|
2021
Q1 | $127K | Sell |
1,700
-547
| -24% | -$40.9K | ﹤0.01% | 1835 |
|
|
2020
Q4 | $194K | Hold |
2,247
| – | – | ﹤0.01% | 1672 |
|
|
2020
Q3 | $137K | Hold |
2,247
| – | – | ﹤0.01% | 1703 |
|
|
2020
Q2 | $93K | Buy |
2,247
+547
| +32% | +$22.6K | ﹤0.01% | 1773 |
|
|
2020
Q1 | $49K | Sell |
1,700
-21,041
| -93% | -$606K | ﹤0.01% | 1817 |
|
|
2019
Q4 | $1.64M | Hold |
22,741
| – | – | ﹤0.01% | 1095 |
|
|
2019
Q3 | $3.19M | Hold |
22,741
| – | – | 0.01% | 882 |
|
|
2019
Q2 | $4.16M | Buy |
22,741
+4,169
| +22% | +$763K | 0.01% | 822 |
|
|
2019
Q1 | $2.95M | Sell |
18,572
-220
| -1% | -$35K | 0.01% | 893 |
|
|
2018
Q4 | $1.8M | Buy |
18,792
+5,995
| +47% | +$574K | ﹤0.01% | 988 |
|
|
2018
Q3 | $1.81M | Sell |
12,797
-703
| -5% | -$99.3K | ﹤0.01% | 1033 |
|
|
2018
Q2 | $2.11M | Buy |
13,500
+10,676
| +378% | +$1.67M | ﹤0.01% | 986 |
|
|
2018
Q1 | $455K | Buy |
+2,824
| New | +$455K | ﹤0.01% | 1419 |
|